Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 1
2016 2
2017 1
2018 1
2019 2
2020 4
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Yamamura S, Nakano D, Hashida R, Tsutsumi T, Kawaguchi T, Okada M, Isoda H, Takahashi H, Matsuse H, Eguchi Y, Sumida Y, Nakajima A, Gerber L, Younossi ZM, Torimura T. Yamamura S, et al. Among authors: okada m. J Gastroenterol Hepatol. 2021 Mar;36(3):629-636. doi: 10.1111/jgh.15172. Epub 2020 Jul 16. J Gastroenterol Hepatol. 2021. PMID: 32627871 Review.
Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees.
Murayama K, Okada M, Tanaka K, Inadomi C, Yoshioka W, Kubotsu Y, Yada T, Isoda H, Kuwashiro T, Oeda S, Akiyama T, Oza N, Hyogo H, Ono M, Kawaguchi T, Torimura T, Anzai K, Eguchi Y, Takahashi H. Murayama K, et al. Among authors: okada m. Diagnostics (Basel). 2021 Jan 16;11(1):132. doi: 10.3390/diagnostics11010132. Diagnostics (Basel). 2021. PMID: 33467114 Free PMC article.
Effect of skin-capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease.
Kimura S, Tanaka K, Oeda S, Inoue K, Inadomi C, Kubotsu Y, Yoshioka W, Okada M, Isoda H, Kuwashiro T, Akiyama T, Kurashige A, Oshima A, Oshima M, Matsumoto Y, Kawaguchi A, Anzai K, Sueoka E, Aishima S, Takahashi H. Kimura S, et al. Among authors: okada m. Sci Rep. 2021 Aug 2;11(1):15641. doi: 10.1038/s41598-021-94970-3. Sci Rep. 2021. PMID: 34341368 Free PMC article.
Categorization and Characterization of Activities Designed to Help Health-care Professionals Involved in Hepatitis Care Increase Their Awareness of the Disease: The Classification of Hepatitis Medical Care Coordinators.
Kanzaki N, Iwane S, Oeda S, Okada M, Kimura H, Eguchi Y, Fujimoto K. Kanzaki N, et al. Among authors: okada m. Intern Med. 2019 Jul 1;58(13):1825-1834. doi: 10.2169/internalmedicine.1755-18. Epub 2019 Feb 25. Intern Med. 2019. PMID: 30799338 Free PMC article.
Recommendations from primary care physicians, family, friends and work colleagues influence patients' decisions related to hepatitis screening, medical examinations and antiviral treatment.
Okada M, Oeda S, Katsuki N, Iwane S, Kawaguchi Y, Kawamoto S, Tomine Y, Fukuyoshi J, Maeyama K, Tanaka H, Anzai K, Eguchi Y. Okada M, et al. Exp Ther Med. 2020 Apr;19(4):2973-2982. doi: 10.3892/etm.2020.8533. Epub 2020 Feb 18. Exp Ther Med. 2020. PMID: 32256783 Free PMC article.
Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
Inadomi C, Takahashi H, Ogawa Y, Oeda S, Imajo K, Kubotsu Y, Tanaka K, Kessoku T, Okada M, Isoda H, Akiyama T, Fukushima H, Yoneda M, Anzai K, Aishima S, Nakajima A, Eguchi Y. Inadomi C, et al. Among authors: okada m. Hepatol Res. 2020 Jun;50(6):682-692. doi: 10.1111/hepr.13495. Epub 2020 Mar 25. Hepatol Res. 2020. PMID: 32090397
Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1.
Ide T, Eguchi Y, Harada M, Ishii K, Morita M, Morita Y, Sugiyama G, Fukushima H, Yano Y, Noguchi K, Nakamura H, Hisatomi J, Kumemura H, Shirachi M, Iwane S, Okada M, Honma Y, Arinaga-Hino T, Miyajima I, Ogata K, Kuwahara R, Amano K, Kawaguchi T, Kuromatsu R, Torimura T; DAAs Multicenter Study Group. Ide T, et al. Among authors: okada m. PLoS One. 2016 Sep 29;11(9):e0163884. doi: 10.1371/journal.pone.0163884. eCollection 2016. PLoS One. 2016. PMID: 27684567 Free PMC article.
12 results